CVA Family Office’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4K Buy
370
+192
+108% +$2.14K ﹤0.01% 1397
2026
Q1
$1.93K Hold
178
– – ﹤0.01% 1534
2025
Q4
$1.09K Buy
+178
New +$1.06K ﹤0.01% 1087
2025
Q2
– Sell
-114
Closed -$937 – 1417
2025
Q1
$937 Hold
114
– – ﹤0.01% 1126
2024
Q4
$942 Buy
114
+17
+18% +$136 ﹤0.01% 1105
2024
Q3
$742 Buy
97
+49
+102% +$451 ﹤0.01% 1119
2024
Q2
$497 Buy
+48
New +$526 ﹤0.01% 1209

Other funds holding PTEN

CVA Family Office's PTEN Position: Q2 2026 in Review

CVA Family Office increased its Patterson-UTI (PTEN) stake by 108% in Q2 2026, buying an estimated $2.14K and bringing the position to 370 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

CVA Family Office first reported a position in PTEN in Q2 2024 and has held it in 7 quarters since. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • CVA Family Office held 370 shares of Patterson-UTI worth $3.4K as of Q2 2026.
  • CVA Family Office bought 192 Patterson-UTI shares in Q2 2026, an estimated $2.14K.
  • Patterson-UTI made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1397 holding.
  • CVA Family Office first reported a position in Patterson-UTI in Q2 2024 and has held it in 7 quarters since.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.